Chugai Pharmaceutical Co Ltd
TSE:4519
Chugai Pharmaceutical Co Ltd
TSE:4519
Price:
9 125
JPY
4.86%
Market Cap:
¥15.3T
Relative Value
The Relative Value of one
Chugai Pharmaceutical Co Ltd
stock under the Base Case scenario is
4 020.78
JPY.
Compared to the current market price of 9 125 JPY,
Chugai Pharmaceutical Co Ltd
is
Overvalued by 56%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
4 020.78
JPY
Overvaluation 56%
Multiples Across Competitors
Competitors Multiples
Chugai Pharmaceutical Co Ltd Competitors
Chugai Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| JP |
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
14.3T JPY | 11.9 | 34.6 | 23.4 | 23.4 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD | 17.7 | 57 | 38.2 | 41 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
564.7B USD | 6 | 21.1 | 14.7 | 18 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.5B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
294.9B USD | 4.5 | 16.2 | 10.1 | 11.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
226B CHF | 5.2 | 20.2 | 12.7 | 16.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
212.5B GBP | 5.1 | 31.4 | 15 | 21.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.3 | 13 | 9 | 10.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.2B USD | 2.4 | 19.7 | 7.4 | 9.8 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.3B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
